In this exclusive interview with HIT Consultant, Barnes & Thornburg partner Taylor Wirth shares his insight on evaluating market conditions, company readiness, and the pros and cons of funding options for businesses in the life sciences sector. https://bit.ly/3B6vdx5
Heather Mink’s Post
More Relevant Posts
-
In this exclusive interview with HIT Consultant, Barnes & Thornburg partner Taylor Wirth shares his insight on evaluating market conditions, company readiness, and the pros and cons of funding options for businesses in the life sciences sector. https://bit.ly/3YWemVM
To view or add a comment, sign in
-
In this exclusive interview with HIT Consultant, Barnes & Thornburg partner Taylor Wirth shares his insight on evaluating market conditions, company readiness, and the pros and cons of funding options for businesses in the life sciences sector. https://bit.ly/40SxKWe
To view or add a comment, sign in
-
In this exclusive interview with HIT Consultant, Barnes & Thornburg partner Taylor Wirth shares his insight on evaluating market conditions, company readiness, and the pros and cons of funding options for businesses in the life sciences sector. https://bit.ly/49iubeh
To view or add a comment, sign in
-
In this exclusive interview with HIT Consultant, Barnes & Thornburg partner Taylor Wirth shares his insight on evaluating market conditions, company readiness, and the pros and cons of funding options for businesses in the life sciences sector. https://bit.ly/3Z2TZWY
To view or add a comment, sign in
-
Join Judith Hasko and Mat Trachok for myLawCLE’s upcoming webinar, “Key Considerations in Joint Technology Development Agreements: Crucial clauses, common issues, and avoidable risks in life sciences.” The discussion will center around the nuances of Joint Technology Development Agreements (JTDAs), including key considerations and common pitfalls to avoid. Learn more and register here: https://bit.ly/3ZdITjw
To view or add a comment, sign in
-
Why Don’t Life Science Distributors Share Information? In this week’s blog, our CEO, Rory Geoghegan, dives into an interesting question: why many life science distributors are reluctant to share information—and the impact this has on their success in a competitive market. From preserving competitive advantage to navigating complex client relationships, we explore the factors behind this guarded approach. Curious about the full story? Check out the blog post to learn more! https://lnkd.in/eMyXZ_M
To view or add a comment, sign in
-
Every stakeholder experiences the naming process differently. Whether you’re an investor, business owner, or marketer, you’ll benefit from the insights in this LinkedIn Live.
Naming a life science company is hard. But you don’t have to do it alone! Tune in to our live Q&A with industry experts Nicholas Perks, Julie Blasingim, and Jacque Alexander, MBA for tips, tricks, and insights that will help you through this challenging but fulfilling journey. https://lnkd.in/dFctFpVA
To view or add a comment, sign in
-
🌟 Life Sciences Strategy Meeting Recap 🌟 This week, members of our Life Sciences team gathered at our headquarters in Wakefield, MA, while others attended remotely, for an impactful strategy session focused on closing 2024 strong and preparing for a successful 2025. Together, we aligned on key goals, explored new ways to enhance our processes, and collaborated on innovative ideas that will enable us to continue delivering top results. Check out some highlights from the day! More updates to come as we push forward and build an exciting future together! 💪 #LifeSciencesStrategyMeeting
To view or add a comment, sign in
-
For all the Life Science Compliance Leaders out there - hot of the presses deep dive of our Digital Sign-In module - check it out, https://lnkd.in/gyRciJmn.
Groupize Digital Sign-In for Life Sciences Webinar 5/15/24
https://vimeo.com/
To view or add a comment, sign in
-
Very exciting news from COSMIIC and Chris Rexroth in pursuit of getting open source neuroprosthetic devices into the clinic!
Happy to be listed as a collaborator with Thomas Jefferson University and Jefferson Health as our system's use expands to Philly! The GRANND (Grasp-Release Assessment of a Networked Neuroprosthesis Device) study conducted by The MetroHealth System (Cleveland, OH) and Case Western Reserve University is expanding to its second clinical center to explore restoration of hand function after cervical SCI using functional electrical stimulation. https://lnkd.in/eQi82KJ3 Note: The COSMIIC System is the soon-to-be fully open source version of the Networked Neuroprosthesis, which is being used under an Investigational Device Exemption (IDE).
Collaborators
neurorestoration.jefferson.edu
To view or add a comment, sign in